Invention Grant
US07659309B2 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
失效
（1- {3- [3-（4-氰基-3-甲氧基 - 苯基）脲基] - 苯基} - 乙基） - 氨基甲酸-2-氰基-1-乙基 - 乙基酯的多晶型形式
![Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester](/docs/US/2010-02-09/US07659309B2/abs.jpg.600x600.jpg)
- Patent Title: Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
- Patent Title (中): （1- {3- [3-（4-氰基-3-甲氧基 - 苯基）脲基] - 苯基} - 乙基） - 氨基甲酸-2-氰基-1-乙基 - 乙基酯的多晶型形式
-
Application No.: US11086142Application Date: 2005-03-22
-
Publication No.: US07659309B2Publication Date: 2010-02-09
- Inventor: Todd Blythe , Philip Nyce , Yong Cui
- Applicant: Todd Blythe , Philip Nyce , Yong Cui
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Michael C. Badia
- Main IPC: A61K31/27
- IPC: A61K31/27 ; A61K31/23 ; C07C255/51
![Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester](/abs-image/US/2010/02/09/US07659309B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester, processes therein, pharmaceutical compositions thereof, and uses therewith.
Public/Granted literature
Information query
